BFM
CELG

Boothbay Fund Management’s Celgene Corp CELG Stock Holding History

Boothbay Fund Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-151,027
Closed -$15M – 1129
2019
Q3 		$15M Buy
151,027
+1,121
+0.7% +$107K 1.38% 4
2019
Q2 		$13.9M Sell
149,906
-71,655
-32% -$6.8M 1.26% 5
2019
Q1 		$20.9M Buy
221,561
+216,421
+4,211% +$18.9M 2.03% 5
2018
Q4 		$329K Buy
+5,140
New +$379K 0.05% 363
2018
Q3 		– Sell
-5,098
Closed -$405K – 1052
2018
Q2 		$405K Buy
+5,098
New +$423K 0.04% 392
2017
Q2 		– Sell
-1,771
Closed -$220K – 993
2017
Q1 		$220K Buy
+1,771
New +$212K 0.04% 562
2016
Q4 		– Sell
-2,398
Closed -$251K – 1066
2016
Q3 		$251K Buy
2,398
+130
+6% +$14.1K 0.05% 454
2016
Q2 		$224K Buy
+2,268
New +$235K 0.09% 346

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Boothbay Fund Management's CELG Position: Q4 2019 in Review

Boothbay Fund Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 151,027 shares — an estimated $15M sold.

Boothbay Fund Management first reported a position in CELG in Q2 2016 and held it in 8 quarters. The position peaked at $20.9M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Boothbay Fund Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Boothbay Fund Management sold 151,027 Celgene Corp shares in Q4 2019, an estimated $15M.
  • Boothbay Fund Management first reported a position in Celgene Corp in Q2 2016 and held it in 8 quarters.
  • Boothbay Fund Management's Celgene Corp position peaked at $20.9M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.